Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

Rein Therapeutics(RNTX.US)

Event Tracking

Jan20

Rein Therapeutics' LTI-03 Drug Receives Orphan Drug Status in Europe

13:30

Nov18

Voss Capital, LP Becomes a Beneficial Owner of Rein Therapeutics Inc.

22:31

Nov15

Rein Therapeutics released FY2025 9 Months Earnings on November 14, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.7447

04:00

Rein Therapeutics released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2117 (forecast USD -0.24)

04:00

Nov6

Rein Therapeutics Inc. Reports Positive Clinical Trial Results for LTI-03 in Idiopathic Pulmonary Fibrosis

12:30

Aug15

Rein Therapeutics released FY2025 Semi-Annual Earnings on August 14 (EST), with actual revenue of USD 0 and EPS of USD -0.5344

03:00

Schedules & Filings

Schedules

Filings

Nov14

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -5.581 M, EPS -0.2117

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.822 M, EPS -0.282

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -5.501 M, EPS -0.251

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

Rein Therapeutics(RNTX.US)

Rein Therapeutics Stock Performance Chart

Trending